Use of chlorotoxin for targeting of primary brain tumors
- PMID: 9809993
Use of chlorotoxin for targeting of primary brain tumors
Abstract
Gliomas are primary brain tumors that arise from differentiated glial cells through a poorly understood malignant transformation. Although glioma cells retain some genetic and antigenic features common to glial cells, they show a remarkable degree of antigenic heterogeneity and variable mutations in their genome. Glioma cells have recently been shown to express a glioma-specific chloride ion channel (GCC) that is sensitive to chlorotoxin (CTX), a small peptide purified from Leiurus quinquestriatus scorpion venom [N. Ullrich et al, Neuroreport, 7: 1020-1024, 1996; and N. Ullrich and H. Sontheimer, Am. J. Physiol. (Cell Physiol.), 270: C1511-C1521, 1996]. Using native and recombinant 125I-labeled CTX, we show that toxin binding to glioma cells is specific and involves high affinity [dissociation constant (Kd)=4.2 nM] and low affinity (Kd=660 nml) binding sites. In radioreceptor assays, 125I-labeled CTX binds to a protein with Mr=72,000, presumably GCC or a receptor that modulates GCC activity. In vivo targeting and biodistribution experiments were obtained using 125I- and (131)I-labeled CTX injected into severe combined immunodeficient mice bearing xenografted gliomas. CTX selectively accumulated in the brain of tumor-bearing mice with calculated brain: muscle ratios of 36.4% of injected dose/g (ID/g), as compared to 12.4% ID/g in control animals. In the tumor-bearing severe combined immunodeficient mice, the vast majority of the brain-associated radioactivity was localized within the tumor (tumor:muscle ratio, 39.13% ID/g; contralateral brain:muscle ratio, 6.68%ID/g). Moreover, (131)I-labeled CTX distribution, visualized through in vivo imaging by gamma ray camera scans, demonstrates specific and persistent intratumoral localization of the radioactive ligand. Immunohistochemical studies using biotinylated and fluorescently tagged CTX show highly selective staining of glioma cells in vitro, in situ, and in sections of patient biopsies. Comparison tissues including normal human brain, kidney, and colon were consistently negative for CTX immunostaining. These data suggest that CTX and CTX-conjugated molecules may serve as glioma-specific markers with diagnostic and therapeutic potential.
Similar articles
-
Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion.Toxins (Basel). 2015 Mar 27;7(4):1079-101. doi: 10.3390/toxins7041079. Toxins (Basel). 2015. PMID: 25826056 Free PMC article. Review.
-
Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.J Control Release. 2011 Jun 30;152(3):402-10. doi: 10.1016/j.jconrel.2011.03.014. Epub 2011 Mar 22. J Control Release. 2011. PMID: 21435361
-
Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601).Expert Opin Drug Deliv. 2007 Mar;4(2):175-86. doi: 10.1517/17425247.4.2.175. Expert Opin Drug Deliv. 2007. PMID: 17335414 Review.
-
Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.Glia. 2002 Aug;39(2):162-73. doi: 10.1002/glia.10083. Glia. 2002. PMID: 12112367
-
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.Cancer Res. 2001 Apr 1;61(7):2983-95. Cancer Res. 2001. PMID: 11306477
Cited by
-
Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides.Mol Cancer Ther. 2024 Feb 1;23(2):139-147. doi: 10.1158/1535-7163.MCT-23-0256. Mol Cancer Ther. 2024. PMID: 38015557 Free PMC article. Review.
-
Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma.Int J Gen Med. 2023 Sep 11;16:4121-4141. doi: 10.2147/IJGM.S418837. eCollection 2023. Int J Gen Med. 2023. PMID: 37720174 Free PMC article. Review.
-
Optimizing CAR-T Therapy for Glioblastoma.Mol Diagn Ther. 2023 Nov;27(6):643-660. doi: 10.1007/s40291-023-00671-0. Epub 2023 Sep 12. Mol Diagn Ther. 2023. PMID: 37700186 Review.
-
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles.Cancers (Basel). 2023 Jun 28;15(13):3388. doi: 10.3390/cancers15133388. Cancers (Basel). 2023. PMID: 37444498 Free PMC article. Review.
-
Cancer Cell-Specific Fluorescent Prodrug Delivery Platforms.Adv Sci (Weinh). 2023 Jun;10(16):e2207768. doi: 10.1002/advs.202207768. Epub 2023 Apr 7. Adv Sci (Weinh). 2023. PMID: 37026629 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical